Abstract
TMF/ARA160 is a Golgi resident protein whose cellular functions have not been conclusively revealed. Herein we show that TMF/ARA160 can direct the proteasomal degradation of the key cell growth regulator – Stat3. TMF/ARA160 was dispersed in the cytoplasm of myogenic C2C12 cells that were grown under low-serum conditions. The cytoplasmic distribution of TMF/ARA160 was accompanied by its transient association with the tyrosine kinase Fer and with Stat3, which underwent proteasomal degradation under those conditions. Moreover, serum deprivation induced the association of ubiquitinated proteins, with the TMF/ARA160 complex. However, TMF/ARA160 did not bind Stat1, whose cellular levels were increased in serum-starved C2C12 cells. Amino-acid sequence analysis identified a BC-box element in TMF/ARA160 that mediated the binding of this protein to elongin C. Ectopic expression of TMF/ARA160 in serum-starved C2C12 cells drove the ubiquitination and proteasomal degradation of Stat3, an effect that was not caused by TMF/ARA160 devoid of the BC-box motif. Thus, the Golgi apparatus harbors a novel BC-box-containing protein that can direct Stat3 to proteasomal degradation. Interestingly, the level of TMF/ARA160 was significantly decreased in malignant brain tumors, implying a suppressive role of that protein in tumor progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- Stat3:
-
signal transducer and activator of transcription 3
- HIV1:
-
human immunodeficiency 1
- LTR:
-
long-terminal repeat
- AR:
-
androgen receptor
- DMEM:
-
Dulbecco's modified Eagle's medium
- FCS:
-
fetal calf serum
- PBS:
-
phosphate-buffered saline
References
Allard P, Zoubeidi A, Nguyen LT, Tessier S, Tanguay S, Chevrette M, Aprikian A and Chevalier S . (2000). Mol. Cell. Endocrinol., 159, 63–77.
Ben-Dor I, Bern O, Tennenbaum T and Nir U . (1999). Cell Growth Differ., 10, 113–129.
Bowman T, Garcia R, Turkson J and Jove R . (2000). Oncogene, 19, 2474–2488.
Bromberg J and Chen X . (2001). Methods Enzymol., 333, 138–151.
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . (1999). Cell, 98, 295–303.
Chapman JR, Tazaki H, Mallouh C and Konno S . (1999). Mol. Urol., 3, 11–16.
Colanzi A, Suetterlin C and Malhotra V . (2003). Curr. Opin. Cell Biol., 15, 462–467.
Conaway JW, Kamura T and Conaway RC . (1998). Biochim. Biophys. Acta, 1377, M49–M54.
Craig AW, Zirngibl R, Williams K, Cole LA and Greer PA . (2001). Mol. Cell. Biol., 21, 603–613.
Craig KL and Tyers M . (1999). Prog. Biophys. Mol. Biol., 72, 299–328.
Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Forster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW and Alexander WS . (2003). Nat. Immunol., 4, 540–545.
Daino H, Matsumura I, Takada K, Odajima J, Tanaka H, Ueda S, Shibayama H, Ikeda H, Hibi M, Machii T, Hirano T and Kanakura Y . (2000). Blood, 95, 2577–2585.
Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW and Carey RG . (1990). Radiology, 174, 411–415.
DeSalle LM and Pagano M . (2001). FEBS Lett., 490, 179–189.
Fridmann-Sirkis Y, Siniossoglou S and Pelham HR . (2004). BMC Cell Biol., 5, 18.
Garcia JA, Ou SH, Wu F, Lusis AJ, Sparkes RS and Gaynor RB . (1992). Proc. Natl. Acad. Sci. USA, 89, 9372–9376.
Halachmy S, Bern O, Schreiber L, Carmel M, Sharabi Y, Shoham J and Nir U . (1997). Oncogene, 14, 2871–2880.
Hao Q-L, Ferris DK, White G, Heisterkamp N and Groffen J . (1991). Mol. Cell. Biol., 11, 1180–1183.
Hao Q-L, Heisterkamp N and Groffen J . (1989). Mol. Cell. Biol., 9, 1587–1593.
Hauser PJ, Agrawal D, Hackney J and Pledger WJ . (1998). Cell Growth Differ., 9, 847–855.
Hsiao PW and Chang C . (1999). J. Biol. Chem., 274, 22373–22379.
Ihle JN . (2001). Curr. Opin. Cell Biol., 13, 211–217.
Jackson PK and Eldridge AG . (2002). Mol. Cell, 9, 923–925.
Kaelin Jr WG . (2002). Nat. Rev. Cancer, 2, 673–682.
Kamura T, Burian D, Yan Q, Schmidt SL, Lane WS, Querido E, Branton PE, Shilatifard A, Conaway RC and Conaway JW . (2001). J. Biol. Chem., 276, 29748–29753.
Kamura T, Conaway JW and Conaway RC . (2002). Prog. Mol. Subcell. Biol., 29, 1–15.
Kamura T, Sato S, Haque D, Liu L, Kaelin Jr WG, Conaway RC and Conaway JW . (1998). Genes Dev., 12, 3872–3881.
Kim L and Wong TW . (1995). Mol. Cell. Biol., 15, 4553–4561.
Kim L and Wong TW . (1998). J. Biol. Chem., 273, 23542–23548.
Kronfeld-Kinar Y, Vilchik S, Hyman T, Leibkowicz F and Salzberg S . (1999). Cell Growth Differ., 10, 201–212.
Lang R, Pauleau AL, Parganas E, Takahashi Y, Mages J, Ihle JN, Rutschman R and Murray PJ . (2003). Nat. Immunol., 4, 546–550.
Lekanne Deprez RH, Riegman PH, van Drunen E, Warringa UL, Groen NA, Stefanko SZ, Koper JW, Avezaat CJ, Mulder PG and Zwarthoff EC . (1995). J. Neuropathol. Exp. Neurol., 54, 224–235.
Letwin K, Yee S-P and Pawson T . (1988). Oncogene, 3, 621–627.
Lu Z, Joseph D, Bugnard E, Zaal KJ and Ralston E . (2001). Mol. Biol. Cell, 12, 795–808.
Lufei C, Ma J, Huang G, Zhang T, Novotny-Diermayr V, Ong CT and Cao X . (2003). EMBO J., 22, 1325–1335.
Magrassi L, De Fraja C, Conti L, Butti G, Infuso L, Govoni S and Cattaneo E . (1999). J. Neurosurg., 91, 440–446.
Mori K and Kato H . (2002). FEBS Lett., 520, 127–132.
Orlovsky K, Ben-Dor I, Priel-Halachmi S, Malovany H and Nir U . (2000). Biochemistry, 39, 11084–11091.
Orlovsky K, Theodor L, Malovani H, Chowers Y and Nir U . (2002). Oncogene, 21, 4997–5001.
Paulson R, Jackson J, Immergluck K and Bishop JM . (1997). Oncogene, 14, 641–652.
Pawson T, Letwin K, Lee T, Hao Q-L, Heisterkamp N and Groffen J . (1989). Mol. Cell. Biol., 9, 5722–5725.
Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia DH and Dunach M . (2003). Mol. Cell. Biol., 23, 2287–2297.
Priel-Halachmi S, Ben-Dor I, Shpungin S, Tennenbaum T, Molavani H, Bachrach M, Salzberg S and Nir U . (2000). J. Biol. Chem., 275, 28902–28910.
Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA and Haque SJ . (2002). Oncogene, 21, 8404–8413.
Rosato R, Veltmaat JM, Groffen J and Heisterkamp N . (1998). Mol. Cell. Biol., 18, 5762–5770.
Scheffler IE . (2001). Adv. Drug Deliv. Rev., 49, 3–26.
Schwartz Y, Ben-Dor I, Navon A, Motro B and Nir U . (1998). FEBS Lett., 434, 339–345.
Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ and Jove R . (2000). Oncogene, 19, 5419–5427.
Taler M, Shpungin S, Salem Y, Malovani H, Pasder O and Nir U . (2003). Mol. Endocrinol., 17, 1580–1592.
Treier M, Staszewski LM and Bohmann D . (1994). Cell, 78, 787–798.
Walsh K and Perlman H . (1997). Curr. Opin. Genet. Dev., 7, 597–602.
Weisberg S, Ashkenazi E, Israel Z, Attia M, Shoshan Y, Umansky F and Brodie C . (2001). Am. J. Physiol., 159, 1193–1197.
Williams RW and Herrup K . (1988). Annu. Rev. Neurosci., 11, 423–453.
Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P and Yu XF . (2003). Science, 302, 1056–1060.
Zhou Y, Wang S, Gobl A and Oberg K . (2001). Oncology, 60, 330–338.
Acknowledgements
We thank Professor Chaya Brodie for making the Meningioma tumors available to us and Ms A Goldreich for typing this manuscript. This work was supported by grants from the Israel Cancer Research Fund; the Melul Foundation; the Israel Cancer Association in memory of the late Professor N Trainin, from the Weinkselbaum Family Research Fund, a grant from CaPCURE Israel, and a grant from the Horowitz Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perry, E., Tsruya, R., Levitsky, P. et al. TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3. Oncogene 23, 8908–8919 (2004). https://doi.org/10.1038/sj.onc.1208149
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208149
Keywords
This article is cited by
-
DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway
Experimental & Molecular Medicine (2021)
-
SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer
Oncogene (2016)
-
A New Model for Developmental Neuronal Death and Excitatory/Inhibitory Balance in Hippocampus
Molecular Neurobiology (2014)
-
New insights to the ubiquitin–proteasome pathway (UPP) mechanism during spermatogenesis
Molecular Biology Reports (2013)
-
MARCH7 E3 ubiquitin ligase is highly expressed in developing spermatids of rats and its possible involvement in head and tail formation
Histochemistry and Cell Biology (2013)